DLHAX
Price
$22.65
Change
-$0.08 (-0.35%)
Updated
May 23 closing price
Net Assets
649.2M
JNGLX
Price
$63.56
Change
-$0.08 (-0.13%)
Updated
May 23 closing price
Net Assets
4.66B
Interact to see
Advertisement

DLHAX vs JNGLX

Header iconDLHAX vs JNGLX Comparison
Open Charts DLHAX vs JNGLXBanner chart's image
Macquarie Healthcare A
Price$22.65
Change-$0.08 (-0.35%)
VolumeN/A
Net Assets649.2M
Janus Henderson Global Life Sciences D
Price$63.56
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets4.66B
DLHAX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHAX vs. JNGLX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Hold and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.66B vs. DLHAX (649M). JNGLX pays higher dividends than DLHAX: JNGLX (0.34) vs DLHAX (0.10). DLHAX was incepted earlier than JNGLX: DLHAX (18 years) vs JNGLX (26 years). DLHAX (1.25) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. DLHAX (5.00). DLHAX has a lower initial minimum investment than JNGLX: DLHAX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -13.69 vs. DLHAX (-15.94). JNGLX return over 5 years is better than : 6.42 vs. DLHAX (-15.27).
DLHAXJNGLXDLHAX / JNGLX
Total Expense Ratio1.210.80151%
Annual Report Gross Expense Ratio1.250.80156%
Fund Existence18 years26 years-
Gain YTD-4.632-6.37873%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets649M4.66B14%
Annual Yield % from dividends0.100.3428%
Returns for 1 year-15.94-13.69116%
Returns for 3 years-12.155.87-207%
Returns for 5 years-15.276.42-238%
Returns for 10 years10.467.46140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBHCX14.100.05
+0.36%
Neuberger Berman Equity Income C
GEMSX22.330.02
+0.09%
Goldman Sachs Emerging Markets Eq Svc
GLNCX20.92-0.03
-0.14%
MFS Global New Discovery C
TMVIX23.02-0.08
-0.35%
Timothy Plan Large/Mid Cap Value I
APGCX58.44-0.61
-1.03%
AB Large Cap Growth C